According to commentary published in The Lancet Oncology, experts predict that the development of new ways of practicing cancer care as a result of the coronavirus disease 2019 (COVID-19) pandemic will permanently lead to a change in oncology services.
“The pandemic has meant a transformation of every aspect of cancer care, irrespective of treatment, inpatient or outpatient, and radical or palliative intent,” James Spicer of Guy’s and St Thomas’ Hospital NHS Foundation Trust in London, was quoted as saying in the commentary.
Oncology teams have had to begin adopting new ways of practicing to try and minimize the risk to patients and staff while simultaneously optimizing treatment and care. Specifically, treatment regimens have been changed to reduce hospital visits.
“Regimens with less intensive treatment visits are now strongly favored, such as 400 mg pembrolizumab…